Vyome raises $22M to advance dermatology pipeline

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
34
Vyome raises $22M to advance dermatology pipeline

PRINCETON, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Vyome Therapeutics Inc., a clinical-stage specialty pharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes, today announced the closing of a $22 million financing.  Vyome Therapeutics Inc. will primarily use the funds to advance its lead molecule, VB 1953, through phase 2 studies for treatment of moderate to severe acne and for operations.  Part of the funds raised are used for facilitating a secondary transaction.

“The closing of Vyome’s Series D comes at a transformational time for the company, as we prepare to initiate a phase 2b clinical trial with our lead candidate, VB 1953, and as we establish the center of operations and headquarters in the United States through a corporate restructuring exercise,” said Venkateswarlu Nelabhotla (Venkat), chief executive officer of Vyome Therapeutics. “We see this investment as validation of Vyome’s innovative approach to efficient specialty pharmaceutical development and the ability of the company’s scientific platform to help solve the problem of microbial resistance in dermatology.”

The financing was led by Iron Pillar, a venture growth investment fund with locations in Palo Alto and Mumbai. Existing investors, including Perceptive Advisors, Romulus Capital and Kalaari Capital also participated in this round. Concomitant with the investment, Mohanjit Jolly, representing Iron Pillar, and Krishna K. Gupta, representing Romulus Capital, will both join Vyome’s board of directors. Following completion of Vyome’s corporate restructuring, Chris Garabedian has been elevated from director of the Board to executive chairman.

Mohanjit Jolly, Partner at Iron Pillar, added, “We are thrilled to partner with Vyome and cement our long-standing relationship with the co-founders.  This investment fits well with Iron Pillar’s approach of backing visionary entrepreneurs, together with patented platform technologies and products that have the potential to leapfrog the current market.  Our advisors, who are dermatology experts in the U.S., are very encouraged by the early clinical efficacy and safety data from studies of VB 1953, and the depth and quality of science around the novel mechanism.  We look forward to leveraging our cross-border network and U.S. capital markets experience to support Vyome as it seeks to establish itself as a leading specialty pharmaceuticals company.”

About Vyome Therapeutics

Vyome Therapeutics is a clinical stage specialty pharmaceutical company, developing a deep pipeline of novel drugs for treatment of drug-resistant skin pathogens, including antibiotics-resistant P. acnes . The company’s lead drug candidate, VB 1953, will enter phase 2b a clinical trial in the first quarter of 2019. VB 1953 is a topical treatment for antibiotic-resistant acne, which is currently an emerging and unmet need with a potential $2B market opportunity in the US alone. Vyome has a deep pipeline of preclinical new chemical entities, based on its patented Dual Action Rational Therapeutics (DARTs) technology, which are unique in their ability to overcome antimicrobial resistance. Vyome has developed clinically validated antifungal products based on its innovative and patented technology platform Molecular Replacement Therapeutics (MRT™), a platform for which Vyome has recently signed an out-licensing deal of marketing rights with a large specialty pharmaceutical company. Vyome has assembled a world-class team of scientific and business development experts who have a track record of conducting scientific research, developing breakthrough products and building sustainable businesses. More information is available at http://www.vyometx.com and @VyomeTx.

About Iron Pillar

Iron Pillar is a venture growth investor specializing in mid stage technology companies in India and the U.S.-India corridor.  Iron Pillar provides growth capital to proven businesses, focusing on Series B, C and D capital raises, as lead investors.  The 6-member Iron Pillar founding team brings 120 years of combined experience with directly relevant skill sets in venture investing, M&A/IPOs/Exits, operations and technology, and complemented by a renowned panel of global advisors.  We leverage our collective experience and networks in the U.S., India, China and Europe to actively partner with entrepreneurs who are poised to scale their technology businesses.  Additional information is available at https://ironpillarfund.com.

About VB 1953

Vyome’s lead molecule, VB 1953, is a first-in-class topical bactericidal antibiotic candidate with a novel mechanism of action that includes inflammation reducing capabilities as well as the demonstrated ability to treat antibiotic resistant P. acnes strains and currently, a US phase 2b clinical trial is being initiated. In preclinical studies, VB 1953 is active against clindamycin-resistant P. acnes bacteria, has a low emergence of resistance and reduces inflammation. VB 1953 is delivered with a microtechnology gel system that ensures the drug is retained at the site of infection and minimizes systemic exposure. Antibacterial-resistant P.acnes is currently an emerging and unmet need with a potential $2B market opportunity in the US alone.

Media contact:
Michael Tattory
LifeSci Public Relations
(646) 751-4362
mtattory@lifescipublicrelations.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASU's International Enrollment Lead Carries Real Weight

Updated Category News Views 108

Twenty thousand nine hundred twenty-six international students is not a campus footnote; it is a serious operating force moving through Arizona State University and the state around it. ASU has held the No. 1 spot among U.S. public universities hosting international students for six straight years, and the 2026 Open Doors report puts it No. 2 across public and private...

Continue Reading
Neurelis Founder Earns EY's 2026 Top Entrepreneur Honor

Updated Category News Views 95

Some business awards are wallpaper; this one carries real clinical weight. EY US named Craig Chambliss, CEO and co-founder of Neurelis, its Entrepreneur Of The Year 2026 National Overall Award winner. In a sector where plenty of companies talk grandly about changing lives and then vanish into the regulatory fog, the underlying story matters more than the trophy. Neurelis...

Continue Reading
Allooloo's 100M Calls Test Capital Markets AI Data

Updated Category News Views 138

Forty-one point nine thousand issuers is a lot of financial clutter to keep straight, and Allooloo says its machines are getting called on to do precisely that at industrial scale. The Vancouver-based company reported on November 20 that its capital-markets data products now receive 100 million AI-agent calls a month—roughly 3.4 million daily, or 39 per second. That is...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 147

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading
Epiroc Takes Live Remote Drilling to CES 2027 Stage

Updated Category News Views 48

A drill rig chewing through Virginia rock from a Las Vegas convention booth is either a serious industrial-tech moment or an expensive magic trick. At CES 2027, Epiroc intends to make the distinction painfully clear. From January 6 through 9, the Stockholm-based mining-equipment company and Luck Stone will connect Booth 7031 in the LVCC West Hall to a working quarry in...

Continue Reading
Lara Kirchner's Surgical Leadership Earns Recognition

Updated Category News Views 64

Surgical care gets judged in the quiet moments nobody puts on a plaque: a sterile instrument ready when it must be, a handoff done cleanly, a team that does not let a rushed schedule turn into a bad outcome. That is why Lara L. Kirchner's recognition as a Pinnacle Professional of the Year deserves a more serious look than the usual congratulatory confetti. Kirchner is...

Continue Reading
CVS Puts Youth Soccer Stories on Its Store Shelves

Updated Category News Views 76

Two kids with real community ties just got a megaphone most grown-ups never receive. CVS Pharmacy has named Caroline, 9, of Holmes Beach, Florida, and Zoe, 12, of Los Angeles, as the first grand-prize winners of its Home Team Heroes youth soccer contest. Each player’s selected nonprofit soccer organization will receive a $25,000 grant, while their stories will appear on...

Continue Reading
West Virginia SEO Timelines Demand Patience, Not Hype

Updated Category News Views 99

A fresh website with no search footprint is not a race car; it is a pickup stuck in mud, and Sean O'Kelly's view of local SEO in West Virginia puts that inconvenient fact right on the table. Most businesses can expect measurable improvement after three to six months of consistent work, according to the HelloNation article. That is not a glamorous answer, but it is the...

Continue Reading
Triller Lawsuit Puts Merger Disclosures Under a Harsh Light

Updated Category News Views 90

A $0.32 closing price has a way of stripping the paint off a corporate story. The proposed securities class action involving Triller Group, Inc. puts a hard spotlight on a familiar, ugly market sequence: a splashy merger, glowing talk around acquired assets, delayed financial filings, Nasdaq trouble, and then a collapse severe enough to leave shareholders wondering what...

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 27

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched into Cumberland Heights Data Breach Issue

Updated Category News Views 81

Cumberland Heights Foundation took a hit back in 2024 when Federman & Sherwood launched an investigation into a serious data breach that compromised personal information. The foundation discovered unauthorized access to sensitive data on their Microsoft O365 platform, prompting immediate scrutiny of their security practices. The Breach Unpacked: What Went Down? This...

Continue Reading
The Remarkable Growth of Parker Hannifin Stock Over Two Decades

Updated Category News Views 195

Unveiling Parker Hannifin's 20-Year Growth Journey Parker Hannifin (NYSE: PH) has consistently outperformed market expectations over the past twenty years. This company's remarkable growth story is not just about numbers; it’s a narrative blending innovation, strategy, and resilience. With an average annual return of 15.52%, Parker Hannifin has shown an annualized...

Continue Reading
CoStar Group Earnings Preview: What to Expect This Quarter

Updated Category News Views 174

CoStar Group’s Earnings Report On The Horizon Here we are—a big date looming. CoStar Group (NASDAQ:CSGP) is all set to drop its quarterly earnings report on February 24, 2026. Basically, a lot of eyes are glued to this one. It feels like the calm before the storm, right? Investors want that sweet taste of surpassing estimates, not to mention some favorable guidance...

Continue Reading
Richardson's Strategic Acquisition: Pasta Business Expansion

Updated Category News Views 221

Richardson International Expands with Pasta Acquisition Richardson International Limited, through its US subsidiary Richardson (US) Holdings Limited, has taken a significant step in the food processing sector. The company has entered into a definitive agreement to acquire the pasta business of 8th Avenue Food & Provisions, Inc. This exciting development marks a noteworthy...

Continue Reading
Sandvik Reports Key Financial Metrics for Second Quarter

Updated Category News Views 192

Sandvik's Financial Performance Overview In a recent release, Sandvik Aktiebolag has shared its financial metrics from the second quarter, revealing significant developments in order intake and revenue growth. The company, known for its innovative engineering solutions, reported an order intake of SEK 32,206 million, displaying a slight decline compared to the previous...

Continue Reading